Danaher
Business Services · District of Columbia, United States · 10K+ Employees
View Company Info for Free
Overview
Headquarters
2200 Pennsylvania Ave NW Ste 800W, Washi...Phone Number
(202) 828-0850Website
www.danaher.comRevenue
$25.1 BillionStock Symbol
DHRIndustry
ZI Rank: 4
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
11
2
3
6
7
4
About Danaher
Danaher Corporation operates across the biotechnology, life sciences, and diagnostics sectors, delivering integrated solutions that enable the development and manufacture of therapeutic products globally. The company designs and manufactures specialized equipment, consumables, and services that address complex challenges in drug development, laboratory analysis, and clinical diagnostics. Within biotechnology, Danaher provides comprehensive bioprocess technologies and manufacturing support systems that streamline the creation of therapeutics. This includes cell culture media development, chromatography resins, filtration technologies, and single-use hardware alongside design and installation services for complete manufacturing suites. The company also offers laboratory-scale protein purification tools, analytical instruments, and healthcare filtration solutions that serve manufacturers and research institutions. The life sciences division encompasses advanced analytical instrumentationRead more
Danaher Org Chart
GS
Controller & Manager, Cost Accounting
NM
Financial Controller
TD
Vice President & Corporate Controller
MD
Vice President Controller
RM
Business Controller
SL
Finance Controller
MA
Controller
SK
Pall Korea Cum Finance Financial Controller (...
EL
Financial Controller
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Danaher your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Danaher has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Danaher has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Danaher launches new products
Congratulate Masked Content for being promoted to Masked Content at Danaher
Earning: See what the market has to say on Danaher recently announced quarterly report
Danaher, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Danaher is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Danaher had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Danaher
Find 2 more new buyers
Compare CEO
How does Rainer Blair compare against Competing Companies' CEOs?
Rainer Blair
President & Chief Executive Officer at Danahe...
Top 30%
CEO management styleGood
50%Bad
50%VS.
Top 30%
CEO effectiveness to drive business results
Excellent
37%
Good
25%
Average
37%
Poor
0%
Very Bad
0%
Good
73%Bad
26%
Explore company insights
Get a deeper look into Danaher's structure, leadership, and market position:
Company Profile Activity
Activity Insights
Danaher is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Danaher is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Danaher.
Danaher Tech Stack
A closer look at the technologies used by Danaher
Most Recent Scoops
Promotion
Executive Move
Executive Moves, Promotion
Left Company
Executive Move
Executive Moves, Left Company
Open Position
Person-Based
Earnings, Stake & Stock Ownership, Finance
Open Position
Danaher News & Media
Danaher Announces Quarterly Dividend - Sep 15, 2026
Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on October 30, 2026 to...Danaher Announces Quarterly Dividend
WASHINGTON, Sept. 15, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on October 30, 2026 to holders of record on September 30, 2026. ABOUT...Molecular Devices and STEMCELL Technologies Collaborate to Accelerate Adoption of Human-Relevant Organoid Models Through Automation
Validated on the CellXpress.ai® Automated Cell Culture System, the new workflow combines organoid biology expertise and laboratory automation to help researchers reduce variability, expand scale, and move discoveries toward impact with greater confidence SAN JOSE, Calif. and VANCOUVER,...WHO Grants Emergency Use Listing for Cepheid's Xpert® Hemorrhagic Fever Panel Test to Support Ebola Outbreak Response in the DRC
Extensive GeneXpert® Dx system footprint across Africa enables rapid deployment of decentralized molecular testing where it is needed most SUNNYVALE, Calif., Sept. 3, 2026 /PRNewswire/ -- Cepheid, a Danaher company and a leader in molecular diagnostics, today announced that it has...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Danaher
Sign Up For FreeTo access detailed company insights
Danaher Corporation operates across the biotechnology, life sciences, and diagnostics sectors, delivering integrated solutions that enable the development and manufacture of therapeutic products globally. The company designs and manufactures specialized equipment, consumables, and services that address complex challenges in drug development, labora... Read More
